Literature DB >> 884445

Femoral vein thrombosis and total hip replacement.

J D Stamatakis, V V Kakkar, S Sagar, D Lawrence, D Nairn, P G Bentley.   

Abstract

Of 160 patients who underwent total hip replacement, 81 developed venographic evidence of thrombi in the operated leg. In 46 cases (57%) the thrombus originated from the femoral vein, and in 43 of these the exact site of origin was defined by venography. In 34 cases (74%) the thrombus arose from the wall of the femoral vein at the level of the lesser trochanter. This region was studied by intraoperative venography in eight patients undergoing total hip replacement, and in every case severe distortion of the common femoral vein was observed, producing almost total occlusion. We suggest that intraoperative damage to the femoral vein results from manipulation of the leg, and that this is one reason why the operation is followed by a high incidence of deep vein thrombosis in the upper femoral region.

Entities:  

Mesh:

Year:  1977        PMID: 884445      PMCID: PMC1631397          DOI: 10.1136/bmj.2.6081.223

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  Venous thrombosis and pulmonary embolism. A clinico-pathological study in injured and burned patients.

Authors:  S SEVITT; N GALLAGHER
Journal:  Br J Surg       Date:  1961-03       Impact factor: 6.939

2.  Arthroplasty of the hip. A new operation.

Authors:  J Charnley
Journal:  Lancet       Date:  1961-05-27       Impact factor: 79.321

3.  Failure of low-dose heparin to prevent deep-vein thrombosis after hip-replacement arthroplasty.

Authors:  W G Hampson; F C Harris; H K Lucas; P H Roberts; I W McCall; P C Jackson; N L Powell; G E Staddon
Journal:  Lancet       Date:  1974-10-05       Impact factor: 79.321

4.  Prevention of deep-vein thrombosis by low-dose heparin in patients undergoing total hip replacement.

Authors:  G K Morris; A P Henry; B J Preston
Journal:  Lancet       Date:  1974-10-05       Impact factor: 79.321

5.  Dextran 40 and thromboembolism in total hip replacement surgery.

Authors:  J E Rothermel; J B Wessinger; F E Stinchfield
Journal:  Arch Surg       Date:  1973-02

6.  "Delayed" prophylactic anticoagulation: a study of results and complications in 2,012 total hip arthroplasties.

Authors:  M B Coventry; D R Nolan; R D Beckenbaugh
Journal:  J Bone Joint Surg Am       Date:  1973-10       Impact factor: 5.284

7.  The I 125 -labeled fibrinogen test and phlebography in the diagnosis of deep vein thrombosis.

Authors:  V V Kakkar
Journal:  Milbank Mem Fund Q       Date:  1972-01

8.  Prevention of thromboembolic disease after elective surgery of the hip.

Authors:  C M Evarts; E J Feil
Journal:  J Bone Joint Surg Am       Date:  1971-10       Impact factor: 5.284

9.  The origin of deep vein thrombosis: a venographic study.

Authors:  A N Nicolaides; V V Kakkar; E S Field; J T Renney
Journal:  Br J Radiol       Date:  1971-09       Impact factor: 3.039

10.  Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement.

Authors:  S Sagar; D Nairn; J D Stamatakis; F H Maffei; A F Higgins; D P Thomas; V V Kakkar
Journal:  Lancet       Date:  1976-05-29       Impact factor: 79.321

View more
  24 in total

Review 1.  The venous footpump: influence on tissue perfusion and prevention of venous thrombosis.

Authors:  A M Gardner; R H Fox
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

Review 2.  Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.

Authors: 
Journal:  BMJ       Date:  1992-09-05

Review 3.  The postdischarge risk of venous thromboembolism after hip replacement. The role of prolonged prophylaxis.

Authors:  D Bergqvist
Journal:  Drugs       Date:  1996       Impact factor: 9.546

4.  Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial.

Authors:  A Planes; N Vochelle; J Y Darmon; M Fagola; M Bellaud; D Compan; E Saliba; N Weisslinger; Y Huet
Journal:  Drugs       Date:  1996       Impact factor: 9.546

5.  Effect of high-dose corticosteroids on the incidence of deep vein thrombosis after total hip replacement.

Authors:  H E Høgevold; A Høiseth; O Reikerås
Journal:  Arch Orthop Trauma Surg       Date:  1991       Impact factor: 3.067

Review 6.  Venous thromboembolic prophylaxis for hip fractures.

Authors:  D Marsland; S C Mears; S L Kates
Journal:  Osteoporos Int       Date:  2010-11-06       Impact factor: 4.507

7.  Prevalence of deep venous thrombosis in the lower extremities of children in the intensive care unit.

Authors:  G A DeAngelis; J McIlhenny; D F Willson; S Vittone; S J Dwyer; J C Gibson; B A Alford
Journal:  Pediatr Radiol       Date:  1996-11

Review 8.  Economics of thromboprophylaxis in total hip replacement surgery.

Authors:  J Harrison; D J Warwick; J Coast
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

9.  Automated venous occlusion plethysmograph.

Authors:  A M Sinton; A D Seagar; F M Davis
Journal:  Med Biol Eng Comput       Date:  1988-05       Impact factor: 2.602

10.  Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.

Authors:  P F Leyvraz; F Bachmann; J Hoek; H R Büller; M Postel; M Samama; M D Vandenbroek
Journal:  BMJ       Date:  1991-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.